Congenital hyperinsulinism is a clinical syndrome of pancreatic β-cell dysfunction characterized by failure to suppress insulin secretion in the presence of hypoglycemia. Here, we describe the concerns, the techniques used to ameliorate these potential problems, and the outcomes for a child with this condition undergoing cardiopulmonary bypass for correction of an atrial septal defect.
GlaserB. Hyperinsulinism of the newborn. Semin Perinatol. 2000;24(2):150–163.
2.
NajmaiiSRedfordDLarsonDF. Hyperglycemia as an effect of cardiopulmonary bypass: intra-operative glucose management. J Extra Corpor Technol. 2006;38(2):168–173.
3.
FlohAAManlhiotCRedingtonAN, et al.Insulin resistance and inflammation are a cause of hyperglycemia after pediatric cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 2015;150(3):498–504.e1.
4.
DoenstTWijeysunderaDKarkoutiK, et al.Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130(4):1144.
5.
KuntschenFRGallettiPMHahnCArnulfJJIsettaCDorV. Alterations of insulin and glucose metabolism during cardiopulmonary bypass under normothermia. J Thorac Cardiovasc Surg. 1985;89(1):97–106.
6.
HogueCWJrPalinCAArrowsmithJE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg. 2006;103(1):21–37.
7.
AgusMSSteilGMWypijD, et al.Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367(13):1208–1219.
